title: A rock and a hard place: The selective serotonin reuptake inhibitor dilemmas in addressing perinatal mood and anxiety disorders.
abstract: Untreated perinatal depression and anxiety increase the risk of pregnancy complications, introducing significant maternal and neonatal complications. Unfortunately, antidepressant treatment with selective serotonin reuptake inhibitors (SSRIs) is similarly associated with adverse perinatal outcomes. Providers should consider all maternal and fetal outcomes when addressing this dilemma.
authors.affiliation: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology Harbor-UCLA Medical Center, UCLA David Geffen School of Medicine, Torrance, CA, USA.
authors.forename: H
authors.initials: H
authors.lastname: Stohl
authors.affiliation: Department of Psychiatry, Kaiser Permanente - Baldwin Park, Baldwin Park, CA, USA.
authors.forename: A D
authors.initials: AD
authors.lastname: Kohm
authors.affiliation: Department of Psychiatry and Behavioral Sciences, University of Southern California Keck School of Medicine, LA, CA, USA.
authors.forename: E
authors.initials: E
authors.lastname: Dossett
mesh_terms: D000022:Abortion, Spontaneous / Q000139:chemically induced*; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018811:Maternal Exposure; D009035:Mothers / Q000523:psychology*; D018743:Perinatal Care / Q000379:methods*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000523:psychology*; D011297:Prenatal Exposure Delayed Effects; D018570:Risk Assessment; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors